BusinessCircleBusinessCircle
  • Home
  • SMEs
  • Startups
  • Markets
  • Finances
  • HR
  • Marketing & Sales
  • Technology
Facebook Twitter Instagram
Sunday, June 1
  • About us
  • Advertise with us
  • Submit Articles
  • Privacy Policy
  • Contact us
BusinessCircleBusinessCircle
  • Home
  • SMEs
  • Startups
  • Markets
  • Finances
  • HR
  • Marketing & Sales
  • Technology
Subscribe
BusinessCircleBusinessCircle
Finances

Sylvamo downgraded to Sector Perform at RBC Capital (NYSE:SLVM)

Business CircleBy Business CircleAugust 10, 2023No Comments2 Mins Read

[ad_1]

Sylvamo (NYSE:SLVM) on Thursday was downgraded to Sector Carry out from a earlier funding score of Outperform by analysts at RBC Capital Markets. They stated the maker of printing paper faces weak demand and destocking tendencies in Europe and North America.

“Whereas uncoated freesheet (UFS) demand has been very sluggish by way of H1 2023 (year-over-year, demand is down 17% in North America, down 22% in Europe and down 7% in Latin America), administration is taking a longer-term view on demand tendencies,” Paul C. Quinn, analyst at RBC, stated in an August 10 report.

RBC lowered its earnings estimates and minimize its value goal for Sylvamo (SLVM) to $44 a share from $55 a share, based mostly on a a number of of about 5 occasions Ebitda of $575 million for 2024.

Sylvamo (SLVM), whose manufacturers embody Hammermill and HP Papers, on Wednesday stated Q2 gross sales rose 0.8% from a yr earlier to $919 million, lacking the consensus estimate of about $960 million.

Adjusted working earnings fell 45% to $49 million, or $1.14 a share, from $89.9 million, or $2.02 a share, a yr earlier. Adjusted EPS missed the consensus estimate of $1.19.

Sylvamo’s (SLVM) inventory this yr fell 14% by way of August 9, contrasting with a ten% acquire for the Normal & Poor’s 400 midcap inventory index (SP400).

[ad_2]

Source link

Capital downgraded NYSESLVM perform RBC Sector Sylvamo
Business Circle
  • Website

Related Posts

US manufacturing output increases in March; February data revised higher

April 16, 2024

AbbVie to spend $1.9B for long acting injectables (NYSE:ABBV)

April 16, 2024

‘Febrile’ excitement helping early stage AI keep pace with the U.S.

April 16, 2024

Johnson & Johnson (JNJ) earnings Q1 2024

April 16, 2024
Add A Comment

Leave A Reply Cancel Reply

Recent Posts
  • 20bet Nasze Państwo ᐉ Kasyno Internetowego I Zakłady Sportowe 2025
  • Kody Bonusowe I Cotygodniowe Zniżki
  • Bruce Bet Bonusy ️ Bonusy Wyjąwszy Depozytu, Kody Atrakcyjne
  • Brighton Photographer Headshots Portraits Actors Music Creatives Content Photographers Sussex
  • Normal Water, Sanitation In Inclusion To Hygiene Wash Within Emergencies
© 2025 BusinessCircle.co
  • Home
  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact us

Type above and press Enter to search. Press Esc to cancel.